共 193 条
[1]
David Moher AL(2009)Jennifer Tetzlaff, Douglas G Altman, PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Int Med 151 264-269
[2]
Moher D(1999)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. Quality of Reporting of Meta-analyses Lancet. 354 1896-1900
[3]
Eastwood S(2000)Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2008-2012
[4]
Olkin I(2007)Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews BMJ 7 10-91
[5]
Rennie D(2017)AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both BMJ 358 j4008-234
[6]
Stroup DF(2010)Olivia O Cajulis, Raisa Avezova, George Kossan, Laura Chew, Carl A Maida, From Systematic Reviews to Clinical Recommendations for Evidence-Based Health Care: Validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for Grading of Clinical Relevance Open Dentistry J 4 84-926
[7]
Stroup DF(2016)Julian P T Higgins, Deborah M Caldwell, Barnaby C Reeves, Beverley Shea, Philippa Davies, Jos Kleijnen, Rachel Churchill, et al, ROBIS: A new tool to assess risk of bias in systeamtic reviews was developed J Clin Epidemiol 69 225-10
[8]
Berlin JA(2008)GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 924-573
[9]
Morton SC(2020)Jae Hung Jung, Philipp Dahm, Low Methodological Quality of Systematic Reviews Published in the Urological Literature (2016-2018) Urology. 138 5-145
[10]
Olkin I(2020)SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver disease: an umbrella review of systematic reviews BMJ Open Diabetes Research & Care. 8 e001956-282